01 1Hansoh Pharma
01 1DAPAGLIFLOZIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-01-10
Pay. Date : 2017-10-17
DMF Number : 32117
Submission : 2017-11-21
Status : Active
Type : II
20
Jiangsu Hansoh Pharmaceutical Group Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DAPAGLIFLOZIN, with a corresponding US DMF Number 32117.
Remarkably, this DMF maintains an Active status since its submission on November 21, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 10, 2018, and payment made on October 17, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
